Eligo Bioscience
UEI: DRH1MFHJWYG3
• CAGE: FB7U2
Overview
Awardee Type
Parent
Company Description
Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet needs.
Name
Eligo Bioscience
Website
Headquarters
Paris 13, ÎLE-DE-FRANCE
France
France
Most Recent Award
Sept. 1, 2025
Calculating
Federal contract and grant recipient
ELIGO BIOSCIENCE
(UEI DRH1MFHJWYG3, CAGE FB7U2)
is headquartered in Paris 13 ÎLE-DE-FRANCE.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in June 2014 and
federally registered in
July 2019.
Federal Award Analysis
Eligo Bioscience federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ELIGO BIOSCIENCE
UEI
DRH1MFHJWYG3
CAGE Code
FB7U2
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 2, 2014
Initial Registration
July 12, 2019
Last Registration
Sept. 1, 2025
Registration Activation
Sept. 1, 2025
Registration Expiration
Sept. 1, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Country of Incorporation
FRA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No
People
Vendor contacts at Eligo Bioscience
Subcontract Awards
Eligo Bioscience subcontract awards
Grant Awards
Eligo Bioscience direct grants
Subgrant Awards
Eligo Bioscience subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Eligo Bioscience